Activity of Brigatinib in Crizotinib and Ceritinib-Resistant ROS1- Rearranged Non–Small-Cell Lung Cancer

Spremljeno u:
Bibliografski detalji
Izdano u:JCO Precis Oncol
Glavni autori: Hegde, Aparna, Hong, David S., Behrang, Amini, Ali, Siraj M., Juckett, Luke, Meric-Bernstam, Funda, Subbiah, Vivek
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2019
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410165/
https://ncbi.nlm.nih.gov/pubmed/32775947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00267
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items